TULP4

gene
On this page

Also known as TUSPKIAA1397

Summary

TULP4 (TUB like protein 4, HGNC:15530) is a protein-coding gene on chromosome 6q25.3, encoding Tubby-related protein 4 (Q9NRJ4). May be a substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins.

Predicted to be involved in protein ubiquitination. Located in cytoplasm.

Source: NCBI Gene 56995 — RefSeq curated summary.

At a glance

  • GWAS associations: 10
  • Clinical variants (ClinVar): 330 total
  • MANE Select transcript: NM_020245

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:15530
Approved symbolTULP4
NameTUB like protein 4
Location6q25.3
Locus typegene with protein product
StatusApproved
AliasesTUSP, KIAA1397
Ensembl geneENSG00000130338
Ensembl biotypeprotein_coding
OMIM619442
Entrez56995

Gene structure

Transcript identifiers

Ensembl transcripts: 7 — 3 protein_coding_CDS_not_defined, 2 protein_coding, 1 nonsense_mediated_decay, 1 retained_intron

ENST00000367094, ENST00000367097, ENST00000432358, ENST00000613390, ENST00000613994, ENST00000616856, ENST00000620026

RefSeq mRNA: 2 — MANE Select: NM_020245 NM_001007466, NM_020245

CCDS: CCDS34561, CCDS34562

Canonical transcript exons

ENST00000367097 — 14 exons

ExonStartEnd
ENSE00000765520158493573158493717
ENSE00000765522158489588158489732
ENSE00000765523158481055158481289
ENSE00000894205158498669158498812
ENSE00000894207158494753158494846
ENSE00000894209158479751158479975
ENSE00000894211158461563158461729
ENSE00000894213158452134158452268
ENSE00000894215158448996158449176
ENSE00000894217158429736158429897
ENSE00000894219158413065158413193
ENSE00001411602158501678158504178
ENSE00001865172158506578158511828
ENSE00003714570158312465158314268

Expression profiles

Bgee: expression breadth ubiquitous, 274 present calls, max score 98.02.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 12.2730 / max 181.6420, expressed in 1739 samples.

FANTOM5 promoters (5 alternative TSS)

Promoter IDTPM avgSamples expressed
708315.58771520
708305.27521599
708291.1719693
708320.155060
708330.08327

Top tissues by expression

283 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
medial globus pallidusUBERON:000247798.02gold quality
globus pallidusUBERON:000187597.79gold quality
corpus callosumUBERON:000233697.50gold quality
cerebellar vermisUBERON:000472097.29gold quality
inferior vagus X ganglionUBERON:000536397.12gold quality
buccal mucosa cellCL:000233696.91gold quality
lateral globus pallidusUBERON:000247696.86gold quality
superior vestibular nucleusUBERON:000722796.52gold quality
calcaneal tendonUBERON:000370196.49gold quality
ventral tegmental areaUBERON:000269196.42gold quality
medulla oblongataUBERON:000189696.10gold quality
substantia nigra pars reticulataUBERON:000196696.03gold quality
colonic epitheliumUBERON:000039795.71gold quality
pigmented layer of retinaUBERON:000178295.68gold quality
substantia nigra pars compactaUBERON:000196595.66gold quality
subthalamic nucleusUBERON:000190695.58gold quality
nippleUBERON:000203094.76gold quality
inferior olivary complexUBERON:000212794.57gold quality
dorsal motor nucleus of vagus nerveUBERON:000287094.54gold quality
saphenous veinUBERON:000731894.54gold quality
tendonUBERON:000004394.37gold quality
caput epididymisUBERON:000435894.21gold quality
corpus epididymisUBERON:000435994.19gold quality
mammary ductUBERON:000176593.76gold quality
Brodmann (1909) area 46UBERON:000648393.76gold quality
parietal lobeUBERON:000187293.67gold quality
spermCL:000001993.52gold quality
dorsal plus ventral thalamusUBERON:000189793.44gold quality
postcentral gyrusUBERON:000258193.21gold quality
superior surface of tongueUBERON:000737192.96gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-GEOD-93593no10.55
E-ANND-3no0.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

212 targeting TULP4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-5692A100.0074.406850
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-30A-5P100.0076.313233
HSA-MIR-30B-5P100.0076.293248
HSA-MIR-30C-5P100.0076.293248
HSA-MIR-30D-5P100.0076.323233
HSA-MIR-30E-5P100.0076.323242
HSA-MIR-3646100.0073.565283
HSA-MIR-4262100.0073.263931
HSA-MIR-3163100.0077.238605
HSA-MIR-340-5P100.0072.504437
HSA-MIR-3064-3P100.0070.091254
HSA-MIR-196A-1-3P99.9972.152772
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-428299.9975.366408
HSA-MIR-181A-5P99.9972.962995
HSA-MIR-181B-5P99.9972.972996
HSA-MIR-181C-5P99.9972.952996
HSA-MIR-181D-5P99.9973.042997
HSA-MIR-366299.9973.825684
HSA-MIR-186-5P99.9970.833707
HSA-MIR-1212199.9966.64255
HSA-MIR-373-5P99.9875.364753
HSA-MIR-616-5P99.9875.584775
HSA-MIR-480399.9871.993117
HSA-MIR-1213699.9872.815713
HSA-MIR-32-5P99.9875.211964
HSA-MIR-92A-3P99.9875.211960
HSA-MIR-92B-3P99.9875.251955
HSA-MIR-25-3P99.9874.601817

Literature-anchored findings (GeneRIF, showing 2)

  • In Philippines families, overtransmission of alleles to persons born with CL+/-P. Results : We found statistical evidence of association between a marker of TULP4 (rs651333) with CL+/-P (P = .00007). Conclusions : Our results further support the linkage results for the chromosome 6q region and reveal a novel candidate gene for CL+/-P. (PMID:24066709)
  • Effects of Tulp4 deficiency on murine embryonic development and adult phenotype. (PMID:38115643)

Cross-species orthologs

6 orthologs

OrganismSymbolGene ID
danio_reriotulp4aENSDARG00000045911
danio_reriotulp4bENSDARG00000063056
mus_musculusTulp4ENSMUSG00000034377
rattus_norvegicusTulp4ENSRNOG00000018012
drosophila_melanogasterTuspFBGN0039530
caenorhabditis_eleganstub-2WBGENE00022139

Paralogs (5): TULP3 (ENSG00000078246), TULP2 (ENSG00000104804), TULP1 (ENSG00000112041), WDR35 (ENSG00000118965), TUB (ENSG00000166402)

Protein

Protein identifiers

Tubby-related protein 4Q9NRJ4 (reviewed: Q9NRJ4)

Alternative names: Tubby superfamily protein, Tubby-like protein 4

All UniProt accessions (2): Q9NRJ4, A0A087WYH3

UniProt curated annotations — full annotation on UniProt →

Function. May be a substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins.

Subcellular location. Cytoplasm.

Tissue specificity. Expressed mainly in the brain, skeletal muscle, testis and kidney.

Domain organisation. The SOCS box domain mediates the interaction with the Elongin BC complex, an adapter module in different E3 ubiquitin ligase complexes.

Pathway. Protein modification; protein ubiquitination.

Similarity. Belongs to the TUB family.

Isoforms (2)

UniProt IDNamesCanonical?
Q9NRJ4-11yes
Q9NRJ4-22

RefSeq proteins (2): NP_001007467, NP_064630* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000007Tubby_CDomain
IPR001496SOCS_boxDomain
IPR001680WD40_rptRepeat
IPR008983Tumour_necrosis_fac-like_domHomologous_superfamily
IPR015943WD40/YVTN_repeat-like_dom_sfHomologous_superfamily
IPR025659Tubby-like_CHomologous_superfamily
IPR036322WD40_repeat_dom_sfHomologous_superfamily
IPR056159Beta-prop_IFT121_TULP_NDomain

Pfam: PF01167, PF07525, PF24797

UniProt features (32 total): repeat 7, region of interest 6, sequence variant 6, modified residue 5, compositionally biased region 3, splice variant 2, chain 1, sequence conflict 1, domain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9NRJ4-F153.930.21

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (5): 577, 945, 950, 1343, 1374

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-8951664Neddylation

MSigDB gene sets: 202 (showing top): RACCACAR_AML_Q6, HNF1_Q6, CACCAGC_MIR138, HEIDENBLAD_AMPLICON_8Q24_DN, YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN, chr6q25, AML_Q6, WTGAAAT_UNKNOWN, GOBP_POST_TRANSLATIONAL_PROTEIN_MODIFICATION, BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS, COATES_MACROPHAGE_M1_VS_M2_DN, CAIRO_HEPATOBLASTOMA_UP, TGTTTAC_MIR30A5P_MIR30C_MIR30D_MIR30B_MIR30E5P, MARKEY_RB1_ACUTE_LOF_UP, BURTON_ADIPOGENESIS_11

GO Biological Process (1): protein ubiquitination (GO:0016567)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (2): cytoplasm (GO:0005737), cytosol (GO:0005829)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
Post-translational protein modification1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure2
protein modification by small protein conjugation1
binding1
intracellular anatomical structure1
cytoplasm1

Protein interactions and networks

STRING

658 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TULP4MISPQ8IVT2720
TULP4SERAC1Q96JX3593
TULP4F8W876F8W876578
TULP4GTF2H5Q6ZYL4534
TULP4TMEM242Q9NWH2526
TULP4TMEM181Q9P2C4481
TULP4RIMS2Q9UQ26470
TULP4ATPSCKMTQ6P4H8468
TULP4GREB1LQ9C091464
TULP4PCNPQ8WW12461
TULP4IGDCC4Q8TDY8456
TULP4SCAF8Q9UPN6450
TULP4CUL5Q93034445
TULP4KLHL2O95198440
TULP4KCNE4Q8WWG9425

IntAct

20 interactions, top by confidence:

ABTypeScore
CUL5SOCS2psi-mi:“MI:0914”(association)0.880
CUL5SOCS7psi-mi:“MI:0914”(association)0.640
RNF7SOCS7psi-mi:“MI:0914”(association)0.530
NEDD4TULP4psi-mi:“MI:0407”(direct interaction)0.440
ABL1TULP4psi-mi:“MI:0915”(physical association)0.400
SRCTULP4psi-mi:“MI:0915”(physical association)0.400
TULP4FYNpsi-mi:“MI:0915”(physical association)0.400
TULP4PIK3R1psi-mi:“MI:0915”(physical association)0.400
CUL5DDX3Xpsi-mi:“MI:0914”(association)0.350
MAGI1CITpsi-mi:“MI:0914”(association)0.350
ATG16L1ESYT2psi-mi:“MI:0914”(association)0.350
WWP2CCDC85Cpsi-mi:“MI:0914”(association)0.350
FAM168ACCDC85Cpsi-mi:“MI:0914”(association)0.350
RNF7SOCS2psi-mi:“MI:0914”(association)0.350
TULP4CASKpsi-mi:“MI:0914”(association)0.350

BioGRID (40): TULP4 (Affinity Capture-MS), TULP4 (Affinity Capture-RNA), TULP4 (Affinity Capture-RNA), TULP4 (Affinity Capture-MS), TULP4 (Affinity Capture-RNA), TULP4 (Affinity Capture-MS), TULP4 (Affinity Capture-MS), TULP4 (Affinity Capture-MS), TULP4 (Affinity Capture-MS), TULP4 (Affinity Capture-MS), TULP4 (Affinity Capture-MS), TSEN15 (Affinity Capture-MS), BAG3 (Affinity Capture-MS), STXBP4 (Affinity Capture-MS), CASK (Affinity Capture-MS)

ESM2 similar proteins: A1ZA47, B6RSP1, O14964, O17583, O35625, O42400, O54916, O60885, O74252, O75553, P0C090, P15330, P16554, P49757, P57094, P97318, P98078, Q0V8S0, Q21502, Q24212, Q24478, Q2LC84, Q5F464, Q5TYQ8, Q5XI07, Q62415, Q641G3, Q69ZW3, Q6DFF2, Q6NUC6, Q75BK1, Q8BG30, Q8CJH2, Q8IPJ3, Q8NDI1, Q96D71, Q96KQ4, Q9BGX5, Q9H3P2, Q9HBD1

Diamond homologs: A0A644F0T7, Q9JIL5, Q9NRJ4, A8WN62, B0WI30, B0XFQ9, B3MDU3, B3NJY0, B4H4X0, B4I7J9, B4J6R7, B4KNA9, B4LMR9, B4MKC7, B4P9H8, B4QFM2, O00294, O00295, O75386, O88413, O88808, P46686, P50586, P50607, Q09306, Q0WPY0, Q10LG8, Q16IR1, Q16KI5, Q28X18, Q2QXB2, Q53PP5, Q5QM27, Q688Y7, Q68Y48, Q69U54, Q6NPQ1, Q6Z2G9, Q75HX5, Q7PZK5

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 18 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

GO biological processes:

GO termPartnersFoldFDR
protein ubiquitination716.1×5e-05
proteasome-mediated ubiquitin-dependent protein catabolic process514.5×7e-04
intracellular signal transduction612.7×3e-04

Disease & clinical

Clinical variants and AI predictions

ClinVar

330 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance281
Likely benign20
Benign3

Top pathogenic / likely-pathogenic (0)

SpliceAI

3600 predictions. Top by Δscore:

VariantEffectΔscore
6:158429733:AAGGT:Aacceptor_gain1.0000
6:158429735:GG:Gacceptor_loss1.0000
6:158429735:GGTGA:Gacceptor_gain1.0000
6:158429895:CAGG:Cdonor_loss1.0000
6:158429896:AG:Adonor_loss1.0000
6:158452132:A:AGacceptor_gain1.0000
6:158452132:AGAT:Aacceptor_gain1.0000
6:158452133:G:GTacceptor_gain1.0000
6:158452133:GAT:Gacceptor_gain1.0000
6:158452133:GATG:Gacceptor_gain1.0000
6:158452265:AAAG:Adonor_loss1.0000
6:158452267:AGG:Adonor_loss1.0000
6:158452268:GGTAC:Gdonor_loss1.0000
6:158452269:GTAC:Gdonor_loss1.0000
6:158452270:T:Gdonor_loss1.0000
6:158461558:TTCA:Tacceptor_loss1.0000
6:158461559:TCA:Tacceptor_loss1.0000
6:158461560:CA:Cacceptor_loss1.0000
6:158461561:A:AGacceptor_gain1.0000
6:158461561:AGAG:Aacceptor_gain1.0000
6:158461562:G:GAacceptor_gain1.0000
6:158461562:GA:Gacceptor_gain1.0000
6:158461562:GAGG:Gacceptor_gain1.0000
6:158461562:GAGGT:Gacceptor_gain1.0000
6:158461728:AGG:Adonor_loss1.0000
6:158461729:GGTA:Gdonor_loss1.0000
6:158461730:G:Cdonor_loss1.0000
6:158479750:GC:Gacceptor_gain1.0000
6:158479904:G:GTdonor_gain1.0000
6:158479972:CAAG:Cdonor_loss1.0000

AlphaMissense

10049 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
6:158314080:T:AW22R1.000
6:158314080:T:CW22R1.000
6:158314153:T:CL46P1.000
6:158314249:T:CL78P1.000
6:158413080:T:AW90R1.000
6:158413080:T:CW90R1.000
6:158413082:G:CW90C1.000
6:158413082:G:TW90C1.000
6:158413102:T:CL97P1.000
6:158413105:C:AA98D1.000
6:158413129:T:AI106K1.000
6:158413137:T:AW109R1.000
6:158413137:T:CW109R1.000
6:158413158:T:AW116R1.000
6:158413158:T:CW116R1.000
6:158413160:G:CW116C1.000
6:158413160:G:TW116C1.000
6:158413171:T:AL120Q1.000
6:158413171:T:CL120P1.000
6:158429746:T:CF131S1.000
6:158429751:T:AW133R1.000
6:158429751:T:CW133R1.000
6:158429752:G:CW133S1.000
6:158429753:G:CW133C1.000
6:158429753:G:TW133C1.000
6:158429763:G:AG137R1.000
6:158429763:G:CG137R1.000
6:158429764:G:AG137E1.000
6:158429764:G:TG137V1.000
6:158429776:T:CL141P1.000

dbSNP variants (sampled 300 via entrez): RS1000001719 (6:158292667 C>T), RS1000002267 (6:158230668 T>C), RS1000004803 (6:158461424 A>G), RS1000040495 (6:158329922 A>G), RS1000041505 (6:158396225 C>T), RS1000047133 (6:158319152 C>T), RS1000052794 (6:158464721 GA>G,GAA), RS1000053269 (6:158381949 T>C), RS1000069453 (6:158253072 A>G), RS1000085534 (6:158333859 C>A), RS1000087026 (6:158437003 A>G), RS1000096463 (6:158230808 T>C), RS1000100374 (6:158475263 C>T), RS1000106776 (6:158415349 C>T), RS1000107623 (6:158332452 G>C)

Disease associations

OMIM: gene MIM:619442 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

10 associations (top):

StudyTraitp-value
GCST000817_105Height2.000000e-09
GCST002647_63Height2.000000e-15
GCST003127_10Lipoprotein (a) levels4.000000e-10
GCST006979_717Heel bone mineral density1.000000e-13
GCST008163_104Height7.000000e-06
GCST008163_248Height8.000000e-07
GCST012232_12Lipoprotein (a) levels5.000000e-12
GCST90000025_138Appendicular lean mass6.000000e-23
GCST90002400_597Plateletcrit5.000000e-11
GCST90002407_533White blood cell count1.000000e-10

EFO canonical traits (4, from GWAS)

EFO IDTrait name
EFO:0006925lipoprotein A measurement
EFO:0009270heel bone mineral density
EFO:0004980appendicular lean mass
EFO:0007985platelet crit

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

36 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyreneaffects methylation, decreases expression5
bisphenol Adecreases methylation, affects cotreatment, decreases expression2
Tretinoindecreases expression, increases expression2
Cadmium Chlorideincreases expression2
aristolochic acid Idecreases expression1
GSK-J4increases expression1
FR900359affects phosphorylation1
dicrotophosincreases expression1
triphenyl phosphateaffects expression1
geraniolincreases expression1
sodium arseniteincreases expression1
butyraldehydedecreases expression1
potassium chromate(VI)affects cotreatment, decreases expression1
2,3-bis(3’-hydroxybenzyl)butyrolactoneaffects cotreatment, decreases expression1
aflatoxin B2increases methylation1
epigallocatechin gallatedecreases expression, increases expression, affects cotreatment1
CGP 52608affects binding, increases reaction1
Vorinostatdecreases expression1
Leflunomideincreases expression1
Panobinostatincreases expression1
Acetaminophenincreases expression1
Camptothecindecreases expression1
Cisplatindecreases expression1
Coumestrolaffects cotreatment, decreases expression1
Dexamethasoneaffects cotreatment, decreases expression1
Indomethacinaffects cotreatment, decreases expression1
Mercuric Chloridedecreases expression1
Urethaneincreases expression1
Valproic Acidincreases methylation1
Vincristineincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.